shakerzandmoverz

[Xplosivestocks]

That is a big win for them

[thewinningstock]

Mover today WGAT high alert

[thewinningstock]

symbol: NEXM, NexMed, Inc., a pharmaceutical and medical technology company, engages in the development of transdermal products based on its proprietary NexACT drug delivery technology.

[thewinningstock]

symbol: NTRZ NutraCea Closes $10M Credit Facility Financing With Wells Fargo Bank

[thewinningstock]

Radars NTRZ, NEXM, GLCC, AESO, SUWN, HPSO, WGAT

[thewinningstock]

Shaker today may not be a shaker tomorrow just remember that

[GuruTrader]

Shakerzzzzzzzzzzzzzzzzz

[GuruTrader]

LOL

[GuruTrader]

Shakerzzzzzzzzzzzzzzzzzzzzzzzz

[GuruTrader]

shakerzzzzzzzzzzzzzzzzzzzzzzzz

[GuruTrader]

i hear ya bro... i hear ya

[GuruTrader]

lol

[BUBBA]

Playing with the options bud. Less risk, less stress and more profits.

[GuruTrader]

Bubbaaaaaaaaaaaaaaaa... whats going on man

[BUBBA]

Morning ya'll, busy board here.

[traderdogzz]

RCTY ALERT....

[FillTheGap]

LBSU +16% today on 391k shares. Paper thin!

[traderdogzz]

RCTY ALERT

[shakerzzz]

they post on momentum players

[kraigger23]

I see no one post here anymore WHY?....

[shakerzzz]

yes letz post winnerz here > ill put some up also bud > good work

[kraigger23]

Is there a problem with me being here. I am happy not to post I gave you WFYW a few weeks ago, you pissed on it and called it a dog.

I gave you two more can you tell me what they were? I can!!!! Yes they were PM to you.

While everyone is abandoning this board you should be happy people still want to put up winners.

The reason for my being gone was I took a beating in WRNW funny it is coming back to life the last three days. You want me to post here, write back otherwise I will consider this the point of no return based on your statement.

[shakerzzz]

wow havnt seen this board in years lol

[kraigger23]

RGRP Name Change to KITD
85,200 shares declared short as of April 2008, there is a failure to deliver in shares of RGRP.

News should be out tomorrow/ name change happened at midnight

41,395 shares of RGRP that were failing-to-deliverKITD is NAKED SHORTED
>

[insureman]

CXAC...

Cross Atlantic Commodities Inc.

Short Interest (Shares Short) 7,000
Days To Cover (Short Interest Ratio) 0.0
Short Percent of Float 0.12 %
Short Interest - Prior 10,000
Short % Increase / Decrease -30.00 %
Short Squeeze Ranking™

% From 52-Wk High ($ 0.40 ) %
% From 52-Wk Low ($ 0.00 ) %
% From 200-Day MA ($ 0.01 ) %
% From 50-Day MA ($ 0.01 ) %
Price % Change (52-Week) -99.60 %

Shares Float 5,690,000
Total Shares Outstanding 25,354,340
% Owned by Insiders %
% Owned by Institutions %
Market Cap. 101,417
Trading Volume - Today 12,429,290
Trading Volume - Average 446,300
Trading Volume - Today vs. Average 2784.96 %
Earnings Per Share 0.03
PE Ratio 0.10
Record Date 2008-AprA

Sector Services
Industry Food Wholesale

[stocksablaze]

check out GPGD up .005x.006 now, GOLD + NEWS + BUYOUT--
http://biz.yahoo.com/iw/080424/0390101.html

[Dollar Bill]

whatz up wiz the RNVO Koolaid, still in plazzz?

[shakerzzz]

wow you even found this board with bdrr unreallllllllllllll lol

[investorcg]

Yes on BDRR. With 9 mil CONFIRMED BY TA AND COMPANY float, IHUBBERS can moonshot this

[PokerVertigo]

BDRR - THE NEXT ROCKET READY FOR LIFT OFF!! 0.009's leaving!

[Waverider110]

Shakerzzzz next rocket:

http://biz.yahoo.com/iw/080131/0355338.html

[GuruTrader]

Morning ya'll

[GuruTrader]

Good Morning

[drluck]

PLRS -- NEWS soon about Potential to Treat Parkinson's Disease
Pluristem's PLX Cells Demonstrate Potential to Treat Parkinson's Disease
Pluristem Life Systems, Inc. (OTCBB:PLRS) (DAX:PJT), a bio-therapeutics Company dedicated to the commercialization of products for a variety of malignant, degenerative and auto-immune indications, announced today that Pluristem's PLacenta eXpanded (PLX) cells have been demonstrated in vitro to have properties that the Company believes gives these cells the potential to treat Parkinson’s Disease (PD). PLX cells are Pluristem’s placental-derived mesenchymal stem cells (MSCs) that have been expanded in the Company’s proprietary PluriX™ 3-D bioreactor.

Pluristem Chairman and CEO, Mr. Zami Aberman commented, “These preliminary results are encouraging. We intend to pursue further in vitro and in vivo studies with our PLX cells in the treatment of Parkinson’s Disease as well as other disorders of the central nervous system. As a cellular therapy for PD and other neurodegenerative diseases, our PLX cells could be a readily available source of important enzymes, neurotransmitters and neurotrophic factors." Pluristem believes their future products will participate in the approximate $30 billion therapeutic and regenerative cellular market.

The in vitro assay demonstrated that Pluristem’s PLX cells can be differentiated into dopaminergic neurons. These neurons were found to have properties favorable to cells, which are known to be helpful in treating PD. These properties include the expression of tyrosine hydroxylase, and the finding of elevated nurr1 mRNA levels. Additionally, these neurons were found to secrete favorable neurotrophic factors such as GDNF, BDNF, IGF-1, and astrocytes markers such as S-100-b, GLUL, and GFAP.

About Parkinson’s Disease

PD is a well characterized degenerative neurological disease whose symptoms are felt to be related to damage to dopamine-producing cells in the Central Nervous System (CNS). PD is felt to currently afflict approximately four million people in the western world which represents a multi-billion dollar market annually.

About Pluristem

Pluristem Life Systems, Inc. is a Company dedicated to the commercialization of non-personalized (allogeneic) stem cell therapy products for the treatment of numerous severe degenerative, malignant and autoimmune disorders. The Company's first planned product, PLX-I, targets a $2 billion market and is intended to resolve the global shortfall of matched tissue for bone marrow transplantation (BMT) by improving the engraftment of hematopoietic stem cells (HSCs) contained in umbilical cord blood (CB).

Pluristem's products are derived from mesenchymal stem cells (MSCs) obtained from the placenta and expanded in the Company's proprietary PluriX(TM) 3D bioreactor that imitates the natural microstructure of bone marrow and does not require supplemental growth factors, cytokines or other exogenous materials. Pluristem believes the resultant expanded cells, termed PLX cells, are multipotent and able to differentiate into a variety of cell types as well as being immune-privileged to protect the recipient from immunological reactions that often accompanies transplantation. Pluristem believes their future products will participate in the approximate $30 billion therapeutic and regenerative cellular market.

Pluristem has offices and is incorporated in the USA with research and manufacturing facilities in Isra

[GuruTrader]

Everyone have a safe and fun Labor Day weekend...

[cm3i long termer]

Today should be a another good day for LGMB.

I expect an even better day in volume, and PPS increase.

IMO, if we break through ABLE, we see 0.05

Any thoughts?

Good to see you back wiseinvestor and mikebr.

God Bless

[cm3i long termer]

News out today on LGMB.

Closed up 40% on 368K shares.

A/S @ 75MM shares
O/S @ 46MM shares
Float @ 15 MM shares.

This one is about to rock. IMO

Legend Credit Signs Letter of Intent With a Combat Sports Company
Wednesday August 22, 8:46 am ET

NEW YORK, NY--(MARKET WIRE)--Aug 22, 2007 -- Legend Credit, Inc (OTC BB:LGMB.OB - News) today announced that it has signed a letter of intent with an established promoter of combat sports events.

ADVERTISEMENT
Under the terms of the proposed agreement, Legend Credit plans to develop programming for cable television, Internet streaming, merchandising and licensing, video on demand, and foreign rights sales derived from mixed martial arts events currently being held by the promoter.

Legend's planned promotion partner holds regular shows in the western United States and has been involved in the sport for the past five years. This company has an existing library that Legend hopes to immediately monetize if a definitive agreement is reached.

Mixed martial arts is a sport that is growing in popularity around the world. The sport combines a variety of fighting styles. The sport is regulated in 33 different states and numerous foreign countries. Top mixed martial arts fights have generated pay per view buy rates in excess of one million purchases.

Legend Credit plans to change its name to reflect its new business model if a definitive agreement is reached.

This news release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 including statements regarding our planned entry into the mixed martial arts sport and immediately monetizing the promoter's existing library. These statements are based upon our current expectations and speak only as of the date hereof. Our actual results may differ materially and adversely from those expressed in any forward-looking statements as a result of various risks and uncertainties, including our ability to enter into a definitive agreement, the ability of Legend to fund the exploitation of certain rights, the public acceptance of mixed martial arts, rapid technological change in our markets, changes in demand for our future products, legislative, regulatory and competitive developments and general economic conditions. Our filings with the SEC include other risks that may negatively affect our business, results of operations and financial condition. We undertake no obligation to revise or update publicly any forward-looking statements other than as required by law.


Contact:

Contact
Legend Mobile
Email Contact
(212)-252-2459

[GuruTrader]

Good Morning Ladies and Gents

[StockMD]

Hmmmmmmmmmmmm

[GuruTrader]

Lets see the Money Flow

[greggor62]

Gonna be a hot one today.




EXCS Execute Sports Sales Hit All-Time Highs
TORRANCE, Calif., Jul 9, 2007 (PrimeNewswire via COMTEX) -- Execute Sports Inc.
(EXCS) today announced that it has just completed its largest sales quarter in
the history of the company. Sales for the second quarter exceeded $800K,
representing a 77% increase of same product sales over Q2 '06.

Execute Sports CEO, Geno Apicella, commented, "We are very pleased with the
results from the second quarter. The increase in sales is a direct result from
on-time shipping, quality of product and the hard work of our entire sales team."

In addition, sales from the first two quarters of 2007 have reached $1.355M. This
is an increase of more than 55% over the same period of 2006.

CEO Apicella further commented, "All of our numbers are up from one year ago. We
are now concentrating on selling through our current inventory to reach the
highest sales figures we have ever had. We also expect to receive orders for Fall
delivery which would thrust our sales numbers into all-time highs."

Additional company information, press releases and general commentary can be
viewed by visiting http://www.excs.msprofit.com.

About Execute Sports, Inc.

Based in Torrance, California, Execute Sports, Inc. develops performance products
including wetsuits, vests, and rash guards for the action sports industry. The
Company's brands include Execute Wetsuits, Vests, Accessories and Wakeskates. For
more information, go to http://www.executesports.com.

Certain statements in this press release are forward-looking as defined in the
Private Securities Litigation Reform Act of 1995. Such forward-looking statements
include expectations regarding the ability of the company to continue its growth
and the financial performance thereafter. These statements involve certain risks
and uncertainties that may cause actual results to differ materially from
expectations as of the date of this release. These risks include the ability to
accomplish goals and strategies, anticipated revenue enhancements, general
economic conditions and the level of consumer spending, and numerous other
factors identified in the Company's Form 10-KSB and other filings with the
Securities Exchange Commission.

This news release was distributed by PrimeNewswire, http://www.primenewswire.com

SOURCE: Execute Sports, Inc.
Execute Sports, Inc.
Geno Apicella, CEO
[phone]
[e-mail]

[GuruTrader]

Morning Playaz

[analogdog]

MRXT up 114% on 2.5 million volume .014 x .015

Mark Smith shell merge with Toyshare confirmed!!!!!

LFZA to USSE ...80 cents

FCKN to $3.67

You remember those!

[GuruTrader]

Morning peeps

[_HAWK_]

MNAB news last night and volume this one looking ripe w its loooow float

[GuruTrader]

Echoooooooooooooooo!!!!!!!!!!!!!!!!!!!!!!!!!!!! aka Good Morning peeps

[GuruTrader]

GM Playas

[BUBBA]

Buenos días, bubba está en casa

[GuruTrader]

Good Morning People

[GuruTrader]

Good Morning All